NLRP3 and eosinophilia-myalgia syndrome: The results of this study untangle the activation of TLR1/2 (Pam3CSK4) and NLRP3 pathways, which drive the release of neutrophil NETs and macrophage polarization,[59] promoting chronic inflammation in EMs lesions.